Press Releases

Date	Title	File/s
Aug 02, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 05, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 26, 2024	Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Jun 25, 2024	Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jun 18, 2024	Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Jun 12, 2024	Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
Jun 07, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 14, 2024	Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024	Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
May 03, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)